| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20045027 | HPV | ENSG00000149295.14 | protein_coding | DRD2 | No | No | 1813 | P14416 |
| TVIS20049925 | HPV | ENSG00000149295.14 | protein_coding | DRD2 | No | No | 1813 | P14416 |
| TVIS20025509 | HPV | ENSG00000149295.14 | protein_coding | DRD2 | No | No | 1813 | P14416 |
| TVIS20049443 | HPV | ENSG00000149295.14 | protein_coding | DRD2 | No | No | 1813 | P14416 |
| TVIS44014966 | HTLV-1 | ENSG00000149295.14 | protein_coding | DRD2 | No | No | 1813 | P14416 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | DRD2 |
|---|---|
| DrugBank ID | DB00508 |
| Drug Name | Triflupromazine |
| Target ID | BE0000756 |
| UniProt ID | P14416 |
| Regulation Type | antagonist |
| PubMed IDs | 239169; 30137788; 9081563 |
| Citations | Horn AS, Post ML, Kennard O: Dopamine receptor blockade and the neuroleptics, a crystallographic study. J Pharm Pharmacol. 1975 Aug;27(8):553-63. doi: 10.1111/j.2042-7158.1975.tb09506.x.@@Chokhawala K, Stevens L: Antipsychotic Medications .@@Creese I, Burt DR, Snyder SH: Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. J Neuropsychiatry Clin Neurosci. 1996 Spring;8(2):223-6. doi: 10.1176/jnp.8.2.223. |
| Groups | Approved; Vet_approved |
| Direct Classification | Phenothiazines |
| SMILES | CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F |
| Pathways | |
| PharmGKB | PA451773 |
| ChEMBL | CHEMBL570 |
